The abdominoperineal resection itself is associated with an adverse outcome: The European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer

European Journal of Cancer

Volumn 45, Issue 7, 2009, Pages 1175-1183

  den Dulk, Marcel ^a   Putter, Hein ^a   Collette, Laurence ^b   Marijnen, Corrie A M ^c   Folkesson, Joakim ^d   Bosset, Jean Francois ^e   Rödel, Claus ^f   Bujko, Krzysztof ^g   Påhlman, Lars ^d   van de Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EORTC Headquarters ^*  (Belgium)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

^f GOETHE UNIVERSITY   (Germany)

^g INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Abdominoperineal resection; Circumferential resection margin; Local recurrence; Rectal cancer; Surgical procedure

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ABDOMEN; ADENOCARCINOMA; AGED; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PERINEUM; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; RECTUM; RISK; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 64049095414     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.039     Document Type: Article

References (27)

1. Martijn H., Voogd A.C., van de Poll-Franse L.V., et al. Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer 39 (2003) 2073-2079
2. Madsen P.M., and Christiansen J. Distal intramural spread of rectal carcinomas. Dis Colon Rectum 29 (1986) 279-282
3. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 345 (2001) 638-646
4. Peeters K.C., Marijnen C.A.M., Nagtegaal I.D., et al. The TME Trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
5. Engel A.F., Oomen J.L., Eijsbouts Q.A., Cuesta M.A., and van de Velde C.J.H. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial?. Colorectal Dis 5 (2003) 180-184
6. Martling A.L., Holm T., Rutqvist L.E., et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 356 (2000) 93-96
7. Haward R.A., Morris E., Monson J.R., Johnston C., and Forman D. The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study. Eur J Surg Oncol 31 (2005) 22-28
8. Marr R., Birbeck K., Garvican J., et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242 (2005) 74-82
9. Nagtegaal I.D., van de Velde C.J.H., Marijnen C.A., van Krieken J.H., and Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23 (2005) 9257-9264
10. Påhlman L., Bohe M., Cedermark B., et al. The Swedish rectal cancer registry. Brit J Surg 94 (2007) 1285-1292
11. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med 336 (1997) 980-987
12. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med 351 (2004) 1731-1740
13. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. New Engl J Med 355 (2006) 1114-1123
14. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004) 15-24
15. Sobin L.H., and Wittekind Ch. TNM classification of malignant tumors. 5th ed. (1997), John Wiley & Sons Inc., New York
16. Putter H., Fiocco M., and Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26 (2007) 2389-2430
17. Bossema E.R., Stiggelbout A.M., Baas-Thijssen M.C., van de Velde C.J.H., and Marijnen C.A.M. Patients' preferences for low rectal cancer surgery. Eur J Surg Oncol 34 (2008) 42-48
18. Quirke P., Sebag-Montefiore D., Steele R., et al. Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. J Clin Oncol (Meeting Abstracts) 24 (2006) 3512
19. Holm T., Ljung A., Haggmark T., Jurell G., and Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Brit J Surg 94 (2007) 232-238
20. den Dulk M., Marijnen C.A., Putter H., et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 246 (2007) 83-90
21. West N.P., Finan P.J., Anderin C., et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26 (2008) 3517-3522
22. Bosset J.F., Calais G., Mineur L., et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 23 (2005) 5620-5627
23. Marijnen C.A., Nagtegaal I.D., Klein Kranenbarg E., et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19 (2001) 1976-1984
24. Radu C., Berglund K., Påhlman L., and Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol 87 (2008) 343-349
25. Tulchinsky H., Shmueli E., Figer A., Klausner J.M., and Rabau M. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15 (2008) 2661-2667
26. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Brit J Surg 93 (2006) 1215-1223
27. den Dulk M., Collette L., van de Velde C.J., et al. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 43 (2007) 1821-1828